+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Community Oncology Services Global Market Report 2024

  • PDF Icon

    Report

  • 175 Pages
  • February 2024
  • Region: Global
  • The Business Research Company
  • ID: 5939614
The community oncology services market size has grown rapidly in recent years. It will grow from $53.79 billion in 2023 to $60.31 billion in 2024 at a compound annual growth rate (CAGR) of 12.1%. The growth observed in the historical period can be attributed to increased healthcare expenditure, the rapid expansion of the elderly population, and reforms in health insurance.

The community oncology services market size is expected to see rapid growth in the next few years. It will grow to $89.48 billion in 2028 at a compound annual growth rate (CAGR) of 10.4%. Projected growth in the forecast period is driven by increased healthcare expenditure, the rapid growth of the elderly population, and health insurance reforms. Key trends include a focus on providing telehealth services, escalating investments, fostering partnerships and collaborations, developing individualized service plans, embracing technological advancements, and engaging in mergers and acquisitions.

The demand for community oncology services is expected to surge due to the cost-effectiveness offered by these centers compared to hospital-based care. Community oncology centers provide cancer care services at a notably lower cost per patient per month than hospital-based clinics, as revealed in a report by the Community Oncology Alliance. The cost of cancer care, including chemotherapy treatment, in community-based clinics proves to be significantly more affordable, approximately $12,000 per patient per month compared to about $20,000 in hospital-based oncology clinics. This cost discrepancy is anticipated to fuel the growth of the community oncology services market in the foreseeable future.

The growth of the community oncology services market is further propelled by the increasing demand for chemotherapy treatments. Chemotherapy, a systemic cancer treatment targeting rapidly dividing cells, remains a crucial aspect of cancer care, necessitating comprehensive oncology services. With the rising need for chemotherapy expected to escalate from 10 million to 15 million by 2040, as reported by Healthcare IT News in February 2022, the significance of oncology services in providing comprehensive care is evident. This surge in chemotherapy demand is a significant driver of growth for the community oncology services market.

Major corporations in the community oncology services sector are actively engaging in acquisitions and research collaborations to broaden their service portfolios and offerings. In April 2023, TPG, a US-based private equity firm, and AmerisourceBergen Corporation, a US-based wholesaler, jointly acquired OneOncology for a sum of 2.1 billion dollars. This acquisition reinforces TPG and AmerisourceBergen's foothold in the specialty practice network and augments their solutions within the oncology realm. OneOncology, a US-based entity, focuses on revolutionizing the patient experience while addressing the challenges encountered in community oncology, positioning itself as a leader in cancer care advancement.

Prominent entities in the community oncology services sector are significantly investing in cancer drugs to fortify the battle against cancer. These corporate investments in oncology services serve as a crucial link between delivering high-quality cancer care and sustainable healthcare solutions. Notably, in March 2023, Pfizer, a US-based pharmaceutical powerhouse, merged with Seagen, a US-based biotechnology company, and committed an investment of $43 billion to combat cancer. This strategic move bolsters Pfizer's presence in the oncology domain, intensifying the fight against cancer, a prominent global cause of mortality.

In October 2021, Anova Enterprises, Inc., a US-based healthcare technology company, entered into a partnership with OPN Healthcare, a US-based community oncology company. As part of the collaboration, Anova will provide funding for the expanding OPN Healthcare research program. Additionally, all practices within the OPN network will continue to utilize the AnovaOS technology platform, enhancing patient access to experimental medicines.

Major companies operating in the community oncology services market report are The US Oncology Network, OneOncology, Florida Cancer Specialists & Research Institute (FCS), The Oncology Institute, Community Care Physicians, P.C. (CCP), GenesisCare, CStone Pharma, CARsgen Therapeutics, JW Therapeutics, BeiGene, Nanjing Legend Pharmaceutical & Chemical Co., Ltd., Zai Labare, Taxane HealthCare Pvt Ltd., Getwell Oncology, Novartis Oncology, Celgene, Johnson & Johnson, Janssen Pharma, Pharmacyclics, Healthkind Labs Pvt Ltd., Arlak Biotech, SwisscheM Healthcare Pvt Ltd., Apikos Pharma, Kolaz Biotech, Quironsalud Proton Therapy Centre, The London Clinic England, Institut Gustave Roussy, Netherlands Cancer Institute, European Medical Center, Yauza Medical Center, Celon Pharma, Nebraska Cancer Specialists, Tufts Medical Center, Doctors Medical Center, Oncology Specialists SC, Baptist Cancer Center, Mayo Clinic, Cleveland Clinic, Fred Hutchinson Cancer Research Center, The University of Texas Southwestern Medical Center, Abramson Cancer Center, McKesson Corporation , TUTEUR Argentina, Takeda Pharmaceutical Company Limited, Pierre Fabre Group, Celnova Pharma , King Hussein Cancer Center (KHCC), Princess Noorah Oncology Center (PNOC), King Abdulaziz Medical City, King Faisal Specialist Hospital and Research Centre, King Fahd Specialist Hospital, Prince Sultan Medical Military City, King Saud Medical City, King Abdullah Medical City, Tawam Hospital , Icon Oncology, Eurolab Science Laboratuvar, Yemaachi Biotechnology, Regal Pharmaceuticals Limited, Ocean Road Cancer Institute.

North America was the largest region in the community oncology services market in 2023. Western Europe was the second largest region in the global oncology services market. The regions covered in the community oncology services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the community oncology services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

Primary types of community oncology services are small, medium, and large clinics. Small clinics typically consist of a single oncologist, one office, and a support staff including physician extenders, nurses, pharmacists, pharmacy technicians, and others. Cancers treated include breast, lung, kidney, liver, ovarian, prostate, skin, pancreatic, blood, colorectal, and others, involving therapies such as medical oncology, radiation oncology, surgical oncology, and more.

The community oncology services market research report is one of a series of new reports that provides community oncology services market statistics, including community oncology services industry global market size, regional shares, competitors with a community oncology services market share, detailed community oncology services market segments, market trends and opportunities, and any further data you may need to thrive in the community oncology services industry. This community oncology services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The community oncology services market includes revenues earned by entities by providing diagnostic, corrective and preventive treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary2. Community Oncology Services Market Characteristics3. Community Oncology Services Market Trends and Strategies
4. Community Oncology Services Market - Macro Economic Scenario
4.1. Impact of High Inflation on the Market
4.2. Ukraine-Russia War Impact on the Market
4.3. COVID-19 Impact on the Market
5. Global Community Oncology Services Market Size and Growth
5.1. Global Community Oncology Services Market Drivers and Restraints
5.1.1. Drivers of the Market
5.1.2. Restraints of the Market
5.2. Global Community Oncology Services Historic Market Size and Growth, 2018-2023, Value ($ Billion)
5.3. Global Community Oncology Services Forecast Market Size and Growth, 2023-2028, 2033F, Value ($ Billion)
6. Community Oncology Services Market Segmentation
6.1. Global Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Small Community Oncology Clinics
  • Medium Community Oncology Clinics
  • Large Community Oncology Clinics
6.2. Global Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Kidney Cancer
  • Liver Cancer
  • Ovarian Cancer
  • Prostate Cancer
  • Skin Cancer
  • Pancreatic Cancer
  • Blood Cancer
  • Colorectal Cancer
  • Other Cancers
6.3. Global Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology
  • Other Therapies
7. Community Oncology Services Market Regional and Country Analysis
7.1. Global Community Oncology Services Market, Split by Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Community Oncology Services Market, Split by Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8. Asia-Pacific Community Oncology Services Market
8.1. Asia-Pacific Community Oncology Services Market Overview
Region Information, Impact of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
9. China Community Oncology Services Market
9.1. China Community Oncology Services Market Overview
9.2. China Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
10. India Community Oncology Services Market
10.1. India Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11. Japan Community Oncology Services Market
11.1. Japan Community Oncology Services Market Overview
11.2. Japan Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12. Australia Community Oncology Services Market
12.1. Australia Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13. Indonesia Community Oncology Services Market
13.1. Indonesia Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14. South Korea Community Oncology Services Market
14.1. South Korea Community Oncology Services Market Overview
14.2. South Korea Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15. Western Europe Community Oncology Services Market
15.1. Western Europe Community Oncology Services Market Overview
15.2. Western Europe Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16. UK Community Oncology Services Market
16.1. UK Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17. Germany Community Oncology Services Market
17.1. Germany Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18. France Community Oncology Services Market
18.1. France Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19. Italy Community Oncology Services Market
19.1. Italy Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20. Spain Community Oncology Services Market
20.1. Spain Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21. Eastern Europe Community Oncology Services Market
21.1. Eastern Europe Community Oncology Services Market Overview
21.2. Eastern Europe Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22. Russia Community Oncology Services Market
22.1. Russia Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23. North America Community Oncology Services Market
23.1. North America Community Oncology Services Market Overview
23.2. North America Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24. USA Community Oncology Services Market
24.1. USA Community Oncology Services Market Overview
24.2. USA Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25. Canada Community Oncology Services Market
25.1. Canada Community Oncology Services Market Overview
25.2. Canada Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26. South America Community Oncology Services Market
26.1. South America Community Oncology Services Market Overview
26.2. South America Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27. Brazil Community Oncology Services Market
27.1. Brazil Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28. Middle East Community Oncology Services Market
28.1. Middle East Community Oncology Services Market Overview
28.2. Middle East Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29. Africa Community Oncology Services Market
29.1. Africa Community Oncology Services Market Overview
29.2. Africa Community Oncology Services Market, Segmentation by Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Community Oncology Services Market, Segmentation by Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Community Oncology Services Market, Segmentation by Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
30. Community Oncology Services Market Competitive Landscape and Company Profiles
30.1. Community Oncology Services Market Competitive Landscape
30.2. Community Oncology Services Market Company Profiles
30.2.1. The US Oncology Network
30.2.1.1. Overview
30.2.1.2. Products and Services
30.2.1.3. Strategy
30.2.1.4. Financial Performance
30.2.2. OneOncology
30.2.2.1. Overview
30.2.2.2. Products and Services
30.2.2.3. Strategy
30.2.2.4. Financial Performance
30.2.3. Florida Cancer Specialists & Research Institute (FCS)
30.2.3.1. Overview
30.2.3.2. Products and Services
30.2.3.3. Strategy
30.2.3.4. Financial Performance
30.2.4. The Oncology Institute
30.2.4.1. Overview
30.2.4.2. Products and Services
30.2.4.3. Strategy
30.2.4.4. Financial Performance
30.2.5. Community Care Physicians, P.C. (CCP)
30.2.5.1. Overview
30.2.5.2. Products and Services
30.2.5.3. Strategy
30.2.5.4. Financial Performance
31. Community Oncology Services Market Other Major and Innovative Companies
31.1. GenesisCare
31.2. CStone Pharma
31.3. CARsgen Therapeutics
31.4. JW Therapeutics
31.5. BeiGene
31.6. Nanjing Legend Pharmaceutical & Chemical Co., Ltd
31.7. Zai Labare
31.8. Taxane HealthCare Pvt Ltd
31.9. Getwell Oncology
31.10. Novartis Oncology
31.11. Celgene
31.12. Johnson & Johnson
31.13. Janssen Pharma
31.14. Pharmacyclics
31.15. Healthkind Labs Pvt Ltd
32. Global Community Oncology Services Market Competitive Benchmarking33. Global Community Oncology Services Market Competitive Dashboard34. Key Mergers and Acquisitions in the Community Oncology Services Market
35. Community Oncology Services Market Future Outlook and Potential Analysis
35.1 Community Oncology Services Market in 2028 - Countries Offering Most New Opportunities
35.2 Community Oncology Services Market in 2028 - Segments Offering Most New Opportunities
35.3 Community Oncology Services Market in 2028 - Growth Strategies
35.3.1 Market Trend-based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic and Forecast Inflation Rates
36.4. Research Inquiries
36.5. About the Analyst
36.6. Copyright and Disclaimer

Executive Summary

Community Oncology Services Global Market Report 2024 provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on community oncology services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia-Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis.
  • Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for community oncology services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? This report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
  • The impact of higher inflation in many countries and the resulting spike in interest rates.
  • The continued but declining impact of COVID-19 on supply chains and consumption patterns.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Report Scope

Markets Covered:
1) By Type: Small Community Oncology Clinics; Medium Community Oncology Clinics; Large Community Oncology Clinics
2) By Cancer Type: Breast Cancer; Lung Cancer; Kidney Cancer; Ovarian Cancer; Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer; Other Cancer Types
3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology; Other Therapies

Key Companies Mentioned: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology Institute; Community Care Physicians, P.C. (CCP)

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes

Delivery Format: PDF, Word and Excel Data Dashboard

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • The US Oncology Network
  • OneOncology
  • Florida Cancer Specialists & Research Institute (FCS)
  • The Oncology Institute
  • Community Care Physicians, P.C. (CCP)
  • GenesisCare
  • CStone Pharma
  • CARsgen Therapeutics
  • JW Therapeutics
  • BeiGene
  • Nanjing Legend Pharmaceutical & Chemical Co., Ltd
  • Zai Labare
  • Taxane HealthCare Pvt Ltd
  • Getwell Oncology
  • Novartis Oncology
  • Celgene
  • Johnson & Johnson
  • Janssen Pharma
  • Pharmacyclics
  • Healthkind Labs Pvt Ltd
  • Arlak Biotech
  • SwisscheM Healthcare Pvt Ltd
  • Apikos Pharma
  • Kolaz Biotech
  • Quironsalud Proton Therapy Centre
  • The London Clinic England
  • Institut Gustave Roussy
  • Netherlands Cancer Institute
  • European Medical Center
  • Yauza Medical Center
  • Celon Pharma
  • Nebraska Cancer Specialists
  • Tufts Medical Center
  • Doctors Medical Center
  • Oncology Specialists SC
  • Baptist Cancer Center
  • Mayo Clinic
  • Cleveland Clinic
  • Fred Hutchinson Cancer Research Center
  • The University of Texas Southwestern Medical Center
  • Abramson Cancer Center
  • McKesson Corporation
  • TUTEUR Argentina
  • Takeda Pharmaceutical Company Limited
  • Pierre Fabre Group
  • Celnova Pharma
  • King Hussein Cancer Center (KHCC)
  • Princess Noorah Oncology Center (PNOC)
  • King Abdulaziz Medical City
  • King Faisal Specialist Hospital and Research Centre
  • King Fahd Specialist Hospital
  • Prince Sultan Medical Military City
  • King Saud Medical City
  • King Abdullah Medical City
  • Tawam Hospital
  • Icon Oncology
  • Eurolab Science Laboratuvar
  • Yemaachi Biotechnology
  • Regal Pharmaceuticals Limited
  • Ocean Road Cancer Institute

Methodology

Loading
LOADING...